Medical Device Testing Services Market Report 2026

The medical device testing services market size has grown strongly in recent years. It will grow from $10.18 billion in 2025 to $11.06 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increase in medical device approvals, tightening global regulatory standards, growth of implantable and active devices, expansion of clinical research activities, demand for standardized quality testing.

The medical device testing services market size is expected to see strong growth in the next few years. It will grow to $15.31 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising complexity of combination devices, growth in in-vitro diagnostics demand, increasing focus on patient safety assurance, expansion of global clinical trials, evolution of harmonized regulatory frameworks. Major trends in the forecast period include rising demand for end-to-end regulatory testing services, increasing focus on biocompatibility and sterility validation, growth of outsourced preclinical and clinical testing services, higher testing requirements for active and implantable devices, expansion of comprehensive package and chemistry testing.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device testing services market in the coming years. Chronic diseases are long-term health conditions that persist over an extended period, typically lasting a year or more. These conditions develop due to factors such as an aging population, unhealthy lifestyle choices, and environmental influences. Medical device testing services play a crucial role in the management of chronic diseases by supporting remote patient monitoring (RPM) and enabling real-time detection of health changes. These services ensure the safety, effectiveness, reliability, and quality of devices, ultimately enhancing patient outcomes and quality of life. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that approximately 129 million people in the United States have at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the medical device testing services market.

Major companies operating in the medical device testing services market are focusing on the implementation of technological advancements, such as innovative medical device testing services, to offer comprehensive testing solutions. These services encompass a variety of tests performed by specialized firms to ensure the safety, effectiveness, and regulatory compliance of medical devices with both national and international standards. For example, in October 2023, UL Solutions, a US-based provider of testing, inspection, and certification services, introduced new medical device testing services at its laboratory in Rochester Hills. These services include compliance training for medical device manufacturers, usability testing, and third-party verification and validation. They contribute to the growth of the state’s medical device sector and assist manufacturers in enhancing the safety, security, usability, and interoperability of their devices. Furthermore, they also offer third-party verification and validation, cybersecurity services, auditing, usability testing, and compliance training to medical device manufacturers, while addressing potential risks such as quality, safety, and cybersecurity challenges, all without hindering innovation and ensuring user protection.

In January 2025, Applus Laboratories, a Spain-based testing, inspection, and certification company, acquired DE Testing Co., Ltd. for an undisclosed amount. Through this acquisition, Applus Laboratories seeks to broaden its testing and inspection capabilities in the Asia-Pacific region, reinforce its local market presence, and improve service offerings for industrial and consumer products. DE Testing Co., Ltd. is a China-based technology company specializing in laboratory testing, quality assurance, and certification services across various industries.

Major companies operating in the medical device testing services market are Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS SA, Bureau Veritas SA, WuXi AppTec Group, Steris plc, Sartorius AG, Charles River Laboratories International Inc., Altran Corporation, TUV SUD AG, Element Minnetonka, Underwriters Laboratories LLC, Intertek Group Plc., QTS Analytical Limited, Pace Analytical Services LLC, Sterigenics International LLC, Nelson Laboratories LLC, Exova Group Limited, Mérieux NutriSciences Corporation, American Preclinical Services LLC, Toxikon Corporation, North American Science Associates Inc., Avomeen Analytical Services LLC, Element Materials Technology Group Limited, Sionic Advisors LLC, Medical Engineering Technologies Ltd.

Asia-Pacific was the largest region in the medical device testing services market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the medical device testing services market by raising costs for imported laboratory equipment, reagents, and testing consumables. Regions such as asia-pacific, europe, and north america are most affected due to reliance on international supply chains. Increased tariffs can elevate service pricing and extend testing timelines. However, they also encourage investments in domestic testing facilities and strengthen regional testing capabilities.

The medical device testing services market research report is one of a series of new reports that provides medical device testing services market statistics, including medical device testing services industry global market size, regional shares, competitors with a medical device testing services market share, detailed medical device testing services market segments, market trends and opportunities, and any further data you may need to thrive in the medical device testing services industry. This medical device testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical device testing services refer to the processes and procedures conducted to evaluate the safety, efficacy, reliability, and quality of medical devices. These services are crucial in ensuring that medical devices meet regulatory standards and requirements before they can be marketed and used for clinical purposes.

The main types of products in medical device testing services are active implant medical devices, active medical devices, non-active medical devices, in-vitro diagnostic medical devices, ophthalmic medical devices, orthopedic and dental medical devices, vascular medical devices, and others. An active implantable medical device (AIMD) is a type of medical device that is designed to be implanted into the body to provide therapy or monitoring. It provides various services, such as biocompatibility tests, chemistry tests, microbiology and sterility tests, and package validation and it included both preclinical and clinical phases.

The medical device testing services market includes revenues earned by entities through services such as sterility testing, packaging testing, electrical safety testing, performance testing, usability testing, and post-market surveillance testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device testing services market also includes sales of testing instruments and equipment, consumables and reagents, mechanical testing machines, electrical safety testers and sterilizers, and autoclaves. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.